Literature DB >> 11672761

Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases.

G Zhang1, C Dai.   

Abstract

The mutations in homocysteine (Hcy) metabolism-related enzyme genes including methylenetetrahydrofolate reductase (MTHFR) C677T, cystathionine beta-synthase (CBS) 844ins68, and methionine synthase (MS) A2756G have been identified as genetic risk factors for thromboembolic events. It has been noticed that these gene mutations have heterogeneous distributions among different ethnic groups or geographic areas. The data on the prevalence of the gene mutations in Chinese population is not yet available. In the present study, we have investigated the frequency of the MTHFR C677T, CBS 844ins68, and MS A2756G mutations in 102 patients with ischemic stroke (IS), 73 patients with myocardial infarction (MI) and 100 healthy controls. The distributive frequencies of the gene variations are as follows: In the IS, MI and control groups, the mutant homozygote for MTHFR C677T is 15 (14.7%), 8 (11.7%) and 16 (16.0%), respectively, and the T allele frequency is 37.7%, 33.6% and 39.5%, respectively; the heterozygote for CBS 844ins68 is 1 (1.0%), 1 (1.4%) and 5 (5.0%), respectively; the heterozygote for MS A2756G is 18 (17.6%), 14 (19.2%) and 17 (17.0%), and the G allele frequency is 8.8%, 11.0% and 9.5%, respectively. The carrier of both MS A2756G and MTHFR C677T (combined mutations) is 14 (12.7%), 8(11.0%) and 12(12.0%), respectively. There is no statistically significant difference between the patient groups and the control group in the frequencies of these single mutation or combined mutations. The heterozygosity of CBS 844ins68 yields an odds ratio (OR) of 0.19 (95% confidence interval (CI) 0.02-1.43) for IS and 0.26 (95% CI 0.03-2.31) for MI. The T allele of MTHFR C677T yields an OR of 0.93 for IS (95% CI 0.62-1.39) and 0.77 for MI (95% CI 0.50-1.21). The G allele of MS A2756G yields an OR of 0.92(95% CI 0.47-1.81) for IS and 1.17 (95% CI 0.58-2.37) for MI. Our results suggest that neither single mutation nor combined mutations in MTHFR C677T, CBS 844ins68 and MS A2756G represent an independent risk factor for increasing IS and coronary artery disease risks in Chinese population. However, CBS 844ins68 may be a protective factor against vascular thromboembolic disease. The prevalence of CBS 844ins68 and MS A2756G in Chinese population is obviously lower than in Western Caucasian population.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11672761     DOI: 10.1016/s0049-3848(01)00352-8

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  15 in total

1.  Identification and functional analysis of cystathionine beta-synthase gene mutations in patients with homocystinuria.

Authors:  Sook-Jin Lee; Dong Hwan Lee; Han-Wook Yoo; Soo Kyung Koo; Eun-Sook Park; Joo-Won Park; Hun Gil Lim; Sung-Chul Jung
Journal:  J Hum Genet       Date:  2005-10-05       Impact factor: 3.172

2.  Association of MTHFR C677T polymorphism and risk of cerebrovascular disease in Chinese population: an updated meta-analysis.

Authors:  Ming-Jie Zhang; Jing-Cheng Li; Yan-Wei Yin; Bing-Hu Li; Yun Liu; Shao-Qiong Liao; Chang-Yue Gao; Li-Li Zhang
Journal:  J Neurol       Date:  2014-03-07       Impact factor: 4.849

Review 3.  Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Growth and Remodeling.

Authors:  Saranya Rajendran; Xinggui Shen; John Glawe; Gopi K Kolluru; Christopher G Kevil
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

4.  Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections.

Authors:  Carsten Konrad; Georg A Müller; Claus Langer; Gregor Kuhlenbäumer; Klaus Berger; Darius G Nabavi; Rainer Dziewas; Florian Stögbauer; Erich B Ringelstein; Ralf Junker
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

5.  Are genetic variants of the methyl group metabolism enzymes risk factors predisposing to obesity?

Authors:  I Terruzzi; P Senesi; I Fermo; G Lattuada; L Luzi
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

6.  B-vitamins, homocysteine and gene polymorphism in adults with fasting or post-methionine loading hyperhomocysteinemia.

Authors:  Chien-Hsiung Cheng; Yi-Chia Huang; Feng-Pan Chen; Ming-Chih Chou; Tsung-Po Tsai
Journal:  Eur J Nutr       Date:  2008-10-31       Impact factor: 5.614

7.  Diversity of cystathionine beta-synthase haplotypes bearing the most common homocystinuria mutation c.833T>C: a possible role for gene conversion.

Authors:  Petr Vyletal; Jitka Sokolová; David N Cooper; Jan P Kraus; Michael Krawczak; Guglielmina Pepe; Olga Rickards; Hans G Koch; Michael Linnebank; Leo A J Kluijtmans; Henk J Blom; Godfried H J Boers; Mette Gaustadnes; Flemming Skovby; Bridget Wilcken; David E L Wilcken; Generoso Andria; Gianfranco Sebastio; Eileen R Naughten; Sufin Yap; Toshihiro Ohura; Ewa Pronicka; Aranka Laszlo; Viktor Kozich
Journal:  Hum Mutat       Date:  2007-03       Impact factor: 4.878

8.  Cystathionine beta-synthase T833C/844INS68 polymorphism: a family-based study on mentally retarded children.

Authors:  Samikshan Dutta; Swagata Sinha; Anindita Chattopadhyay; Prasanta Kumar Gangopadhyay; Jotideb Mukhopadhyay; Manoranjan Singh; Kanchan Mukhopadhyay
Journal:  Behav Brain Funct       Date:  2005-12-26       Impact factor: 3.759

9.  Lack of association of polymorphisms in homocysteine metabolism genes with pseudoexfoliation syndrome and glaucoma.

Authors:  Bao Jian Fan; Teresa Chen; Cynthia Grosskreutz; Louis Pasquale; Douglas Rhee; Elizabeth DelBono; Jonathan L Haines; Janey L Wiggs
Journal:  Mol Vis       Date:  2008-12-26       Impact factor: 2.367

10.  Influence of combined methionine synthase (MTR 2756A > G) and methylenetetrahydrofolate reductase (MTHFR 677C > T) polymorphisms to plasma homocysteine levels in Korean patients with ischemic stroke.

Authors:  Ok Joon Kim; Sun Pyo Hong; Jung Yong Ahn; Seung Ho Hong; Tae Sun Hwang; Soo Ok Kim; Wangdon Yoo; Doyeun Oh; Nam Keun Kim
Journal:  Yonsei Med J       Date:  2007-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.